These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 11966929

  • 21. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY, Mailhot JM.
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [Abstract] [Full Text] [Related]

  • 22. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M.
    J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
    [Abstract] [Full Text] [Related]

  • 23. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.
    Francetti L, Del Fabbro M, Basso M, Testori T, Weinstein R.
    J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
    Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M.
    J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R, Schreiber D, Flores-de-Jacoby L.
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [Abstract] [Full Text] [Related]

  • 30. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV.
    Eur J Oral Implantol; 2009 Oct; 2(4):247-66. PubMed ID: 20467602
    [Abstract] [Full Text] [Related]

  • 31. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
    Heden G, Wennström JL.
    J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
    [Abstract] [Full Text] [Related]

  • 32. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A, Berakdar M, Donos N, Auschill TM, Arweiler NB.
    Clin Oral Investig; 2003 Jun; 7(2):108-12. PubMed ID: 12720115
    [Abstract] [Full Text] [Related]

  • 33. Microsurgical approach to periodontal regeneration. Initial evaluation in a case cohort.
    Cortellini P, Tonetti MS.
    J Periodontol; 2001 Apr; 72(4):559-69. PubMed ID: 11338311
    [Abstract] [Full Text] [Related]

  • 34. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F, Kovács V, Arweiler NB, Huszár T, Gera I, Nikolidakis D, Sculean A.
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [Abstract] [Full Text] [Related]

  • 35. Clinical outcomes of the entire papilla preservation technique with and without biomaterials in the treatment of isolated intrabony defects: A randomized controlled clinical trial.
    Aslan S, Buduneli N, Cortellini P.
    J Clin Periodontol; 2020 Apr; 47(4):470-478. PubMed ID: 31925811
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V, Andreuccetti G, Blasi A, Matarasso M, Sculean A, Salvi GE.
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
    Peres MF, Ribeiro ED, Casarin RC, Ruiz KG, Junior FH, Sallum EA, Casati MZ.
    J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.